-
1
-
-
0003629459
-
-
London: Chapman and Hall
-
Attwood, D., and Florence, A. T. 1983. Surfactant Systems, their Chemistry, Pharmacy, and Biology. London: Chapman and Hall.
-
(1983)
Surfactant Systems, their Chemistry, Pharmacy, and Biology
-
-
Attwood, D.1
Florence, A.T.2
-
2
-
-
0035834250
-
Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels
-
Barreiro-Iglesias, R., Alvarez-Lorenzo, C., and Concheiro, A. 2001. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J. Control. Rel. 77(1-2):59-75.
-
(2001)
J. Control. Rel
, vol.77
, Issue.1-2
, pp. 59-75
-
-
Barreiro-Iglesias, R.1
Alvarez-Lorenzo, C.2
Concheiro, A.3
-
4
-
-
0013694611
-
Vehicle effect: What is an enhancer?
-
ed. Shah, V. P, and Maibach, H. I, New York: Plenum Press
-
Barry, B. W. 1993.Vehicle effect: what is an enhancer? In Topical Drug Bioavailability, Bioequivalence, and Penetration, ed. Shah, V. P., and Maibach, H. I., New York: Plenum Press, 261-276.
-
(1993)
Topical Drug Bioavailability, Bioequivalence, and Penetration
, pp. 261-276
-
-
Barry, B.W.1
-
5
-
-
0025828581
-
The discovery and development of cyclosporine (Sandimmune)
-
Borel, J. F., and Kis, Z. L. 1997. The discovery and development of cyclosporine (Sandimmune). Transplant. Proc. 23:1867-1874.
-
(1997)
Transplant. Proc
, vol.23
, pp. 1867-1874
-
-
Borel, J.F.1
Kis, Z.L.2
-
6
-
-
0030879297
-
Drug delivery from a liquid crystalline base across visking and human stratum corneum
-
Carr, M. G., Earish, S., and Carrign, O. J. 1997. Drug delivery from a liquid crystalline base across visking and human stratum corneum. Int. J. Pharm. 157:35-42.
-
(1997)
Int. J. Pharm
, vol.157
, pp. 35-42
-
-
Carr, M.G.1
Earish, S.2
Carrign, O.J.3
-
7
-
-
0020608231
-
Epidermal lipids, barrier function and desquamation
-
Elias, P. 1983. Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 80:44-49.
-
(1983)
J. Invest. Dermatol
, vol.80
, pp. 44-49
-
-
Elias, P.1
-
8
-
-
2742595465
-
Introductory lecture
-
Flory, P. J. 1994. Introductory lecture. Disc. Faraday Soc. 57:7-18.
-
(1994)
Disc. Faraday Soc
, vol.57
, pp. 7-18
-
-
Flory, P.J.1
-
9
-
-
33847083205
-
-
Hermans, P. H. 1949. Gels. In Colloid Science, ed. Kruyt, H. R. Amsterdam: Elsevier Publishing, 2:483-651.
-
Hermans, P. H. 1949. Gels. In Colloid Science, ed. Kruyt, H. R. Amsterdam: Elsevier Publishing, 2:483-651.
-
-
-
-
11
-
-
0033974937
-
Lecithin vesicular carriers for transdermal delivery of cyclosporine A
-
Jianxin, G., Qineng, P., Guoqin, S., and Chunhong, J. 2000. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int. J. Pharm. 194:201-207.
-
(2000)
Int. J. Pharm
, vol.194
, pp. 201-207
-
-
Jianxin, G.1
Qineng, P.2
Guoqin, S.3
Chunhong, J.4
-
12
-
-
33847061552
-
Preparation and characterization of novel amphiphilogels
-
Glasgow, Scotland, UK
-
Jibry, N., and Murdan, S. 2001. Preparation and characterization of novel amphiphilogels. British Pharmaceutical Conference, Glasgow, Scotland, UK.
-
(2001)
British Pharmaceutical Conference
-
-
Jibry, N.1
Murdan, S.2
-
13
-
-
33847057206
-
Amphiphilogels: Delivery vehicles for poorly-soluble drugs
-
Glasgow, Scotland, UK
-
Jibry, N., Zaman, A. A., and Murdan, S. 2001. Amphiphilogels: delivery vehicles for poorly-soluble drugs, British Pharmaceutical Conference, Glasgow, Scotland, UK.
-
(2001)
British Pharmaceutical Conference
-
-
Jibry, N.1
Zaman, A.A.2
Murdan, S.3
-
14
-
-
6344292470
-
Amphiphilogels for drug delivery: Formulation and characterization
-
Jibry, N., Heenan, R. K., and Murdan, S. 2004. Amphiphilogels for drug delivery: formulation and characterization. Pharm. Res. 21:1852-1861.
-
(2004)
Pharm. Res
, vol.21
, pp. 1852-1861
-
-
Jibry, N.1
Heenan, R.K.2
Murdan, S.3
-
15
-
-
2942679021
-
In vivo investigation, in mice and in man, into the irritation potential of novel amphiphilogels being studied as transdermal drug carriers
-
Jibry, N., and Murdan, S. 2004. In vivo investigation, in mice and in man, into the irritation potential of novel amphiphilogels being studied as transdermal drug carriers. Eur. J. Pharm. BioPharm. 58(1):107-119.
-
(2004)
Eur. J. Pharm. BioPharm
, vol.58
, Issue.1
, pp. 107-119
-
-
Jibry, N.1
Murdan, S.2
-
16
-
-
0037032457
-
Skin permeation enhancement effect and skin irritation of saturated fatty alcohols
-
Kanikkannan, N., and Singh, M. 2002. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int. J. Pharm. 248:219-228.
-
(2002)
Int. J. Pharm
, vol.248
, pp. 219-228
-
-
Kanikkannan, N.1
Singh, M.2
-
17
-
-
0037011426
-
Preparation of a stable double emulsion (W1/O/W2): Role of the interfacial films on the stability of the system
-
Kanouni, M., Rosano, H. L., and Naouli, N. 2002. Preparation of a stable double emulsion (W1/O/W2): role of the interfacial films on the stability of the system. Adv Colloid Interface Sci. 99(3):229-254.
-
(2002)
Adv Colloid Interface Sci
, vol.99
, Issue.3
, pp. 229-254
-
-
Kanouni, M.1
Rosano, H.L.2
Naouli, N.3
-
18
-
-
85119791185
-
-
Lebwohl, M., Ellis, C., Gottlieb, A., Koo, J., Krueger, G., Linden, K., Shupack, J., and Weinstein, G. 1998. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J. Am. Acad. Dermatol. 39:464-475.
-
Lebwohl, M., Ellis, C., Gottlieb, A., Koo, J., Krueger, G., Linden, K., Shupack, J., and Weinstein, G. 1998. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J. Am. Acad. Dermatol. 39:464-475.
-
-
-
-
19
-
-
33644567601
-
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. A prospective, multicenter, 40-week study
-
Lee, W. K., Lee, J., Kim, W. U., Cho, C. S., Kim, H. Y., Ahn, H. J., Han, S. H., et al. 2001. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. A prospective, multicenter, 40-week study. Arthr. Rheum. 44:S1914.
-
(2001)
Arthr. Rheum
, vol.44
-
-
Lee, W.K.1
Lee, J.2
Kim, W.U.3
Cho, C.S.4
Kim, H.Y.5
Ahn, H.J.6
Han, S.H.7
-
20
-
-
33845185315
-
Novel family of gelators of organic fluids and structure of their gels
-
Lin, Y. C., Kachar, B., and Weiss, R. G. 1989. Novel family of gelators of organic fluids and structure of their gels. J. Am. Chem. Soc. 11:5542-5551.
-
(1989)
J. Am. Chem. Soc
, vol.11
, pp. 5542-5551
-
-
Lin, Y.C.1
Kachar, B.2
Weiss, R.G.3
-
21
-
-
2942649346
-
Novel surfactant-in-surfactant amphiphilogels
-
Murdan, S., Ford, J., and Florence, A. T. 1998. Novel surfactant-in-surfactant amphiphilogels. J. Pharm. Pharmacol. 50:151.
-
(1998)
J. Pharm. Pharmacol
, vol.50
, pp. 151
-
-
Murdan, S.1
Ford, J.2
Florence, A.T.3
-
22
-
-
6344284259
-
Amphiphilogel systems as oral delivery vehicles for cyclosporine A: Preliminary in vivo results
-
Murdan, S., Arunothayanun, P., Ford, J., and Florence, A. T. 1999. Amphiphilogel systems as oral delivery vehicles for cyclosporine A: preliminary in vivo results. Proc. Symp. Lipid Surfactant Dispersed Sys. 237-238.
-
(1999)
Proc. Symp. Lipid Surfactant Dispersed Sys
, pp. 237-238
-
-
Murdan, S.1
Arunothayanun, P.2
Ford, J.3
Florence, A.T.4
-
23
-
-
23444460408
-
Novel gels and their dispersions as oral drug delivery systems for cyclosporine
-
Murdan, S., Andrysek, T., and Son, D. 2005. Novel gels and their dispersions as oral drug delivery systems for cyclosporine. Int. J. Pharm. 300(1-2):113-124.
-
(2005)
Int. J. Pharm
, vol.300
, Issue.1-2
, pp. 113-124
-
-
Murdan, S.1
Andrysek, T.2
Son, D.3
-
24
-
-
0028958393
-
Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors
-
Ogiso, T., Iwaki, M., and Paku, T. 1995. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci. 84(4):482-488.
-
(1995)
J. Pharm. Sci
, vol.84
, Issue.4
, pp. 482-488
-
-
Ogiso, T.1
Iwaki, M.2
Paku, T.3
-
25
-
-
0035005262
-
Cyclosporine A eyedrops: Manufacturing, kinetics and indications in 2000
-
Robert, P. Y., Leconte, V., Oliv, E. C., Ratsimbazafy, V., Javerliat, M., and Adenis, J. P. 2001. Cyclosporine A eyedrops: manufacturing, kinetics and indications in 2000. J. Fran. D' Ophtalmol. 24:527-535.
-
(2001)
J. Fran. D' Ophtalmol
, vol.24
, pp. 527-535
-
-
Robert, P.Y.1
Leconte, V.2
Oliv, E.C.3
Ratsimbazafy, V.4
Javerliat, M.5
Adenis, J.P.6
-
26
-
-
0033744481
-
Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporine A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients
-
Rohatagi, S., Calic, F., Harding, N., Ozoux, M. L., Bouriot, J. P., Kirkesseli, S., DeLeij, L., and Jensen, B. K. 2004. Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporine A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients. J. Clin. Pharmacol. 40:1211-1226.
-
(2004)
J. Clin. Pharmacol
, vol.40
, pp. 1211-1226
-
-
Rohatagi, S.1
Calic, F.2
Harding, N.3
Ozoux, M.L.4
Bouriot, J.P.5
Kirkesseli, S.6
DeLeij, L.7
Jensen, B.K.8
-
27
-
-
0034105080
-
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
-
Sall, K., Stevenson, O. D., Mundorf, T. K., and Reis, B. L. 2000. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107:631-639.
-
(2000)
Ophthalmology
, vol.107
, pp. 631-639
-
-
Sall, K.1
Stevenson, O.D.2
Mundorf, T.K.3
Reis, B.L.4
-
28
-
-
0029923360
-
A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
-
Sandborn, W. J. 1996. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am. J. Gastroenterol. 91:423-433.
-
(1996)
Am. J. Gastroenterol
, vol.91
, pp. 423-433
-
-
Sandborn, W.J.1
|